The 2024 Environment+Energy Leader Awards has recognized MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, for its innovative efforts to minimize the environmental impact of scientific research and manufacturing. More specifically, the company won Top Project in the Environmental Impact category for initiatives housed under its Greener Products and Solutions (GP&S) program.

MilliporeSigma was also awarded the distinction of “Judges’ Choice,” scoring the highest amongst all other judges’ evaluations in the category. This special recognition was due to several industry-first projects that stood out to judges for their exceptional achievements.

According to the judges, the GP&S program represents “a solid application that effectively demonstrates the positive impact that pharmaceutical industry suppliers can have on reducing plastics, wastes and greenhouse gas emissions.”

MilliporeSigma’s GP&S program was recognized for helping its business and customers keep sustainability at the forefront of each stage of the product lifecycle by using SHAPE, an industry-first design for sustainability framework. Additionally, judges were impressed by the company’s offering of 2,504 greener alternative products—a 34% increase from 2022. The company also improved packaging sustainability with 400+ metric tons of annual packaging savings since 2019. Also, its proprietary DOZN™ tool, a quantitative green chemistry evaluator, is used by 2,170+ scientists across 78 countries, helping advance greener thinking.

Additionally, demonstrating a commitment to the next generation, its expanded partnership with Beyond Benign, a green chemistry nonprofit, has inspired 834,000+ students to address sustainability through chemistry.

To learn more about the company’s recognition for its GP&S program, please read the Environment+Energy Leader Awards eBook.

More on the company’s sustainability initiatives can be found by visiting its Sustainability & Social Business Innovation webpage.

MilliporeSigma

MilliporeSigma

We holistically integrate sustainability throughout our own operations and across suppliers, reducing the impact of scientific research globally and exceeding customer expectations.

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.  

Around 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

More from MilliporeSigma